Publication:
Heterogeneity on Long-Term Disability Trajectories in Patients With Secondary Progressive MS: A Latent Class Analysis From Big MS Data Network

dc.authorscopusid36545349100
dc.authorscopusid54397364000
dc.authorscopusid6603820898
dc.authorscopusid7005165969
dc.authorscopusid25226936800
dc.authorscopusid7004645696
dc.authorscopusid8365701900
dc.authorwosidMccombe, Pamela/C-9692-2010
dc.authorwosidIaffaldano, Pietro/Afe-8061-2022
dc.authorwosidEichau, Sara/Aaa-8145-2019
dc.authorwosidVan Pesch, Vincent/Aak-9506-2020
dc.authorwosidOzakbas, Serkan/V-6427-2019
dc.authorwosidSignori, Alessio/L-3081-2016
dc.authorwosidSá, Maria/Aad-4527-2021
dc.contributor.authorSignori, Alessio
dc.contributor.authorLorscheider, Johannes
dc.contributor.authorVukusic, Sandra
dc.contributor.authorTrojano, Maria
dc.contributor.authorIaffaldano, Pietro
dc.contributor.authorHillert, Jan
dc.contributor.authorButzkueven, Helmut
dc.contributor.authorIDTomas, Frédéric/0000-0003-0197-3368
dc.contributor.authorIDHillert, Jan/0000-0002-7386-6732
dc.contributor.authorIDLorscheider, Johannes/0000-0003-1100-2506
dc.contributor.authorIDSánchez Menoyo, José Luis/0000-0003-2634-8294
dc.contributor.authorIDSignori, Alessio/0000-0001-6289-9144
dc.contributor.authorIDZhu, Chao/0000-0003-3951-7501
dc.date.accessioned2025-12-11T01:39:30Z
dc.date.issued2023
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Signori, Alessio; Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Lorscheider, Johannes] Univ Basel, Univ Hosp Basel, Neurol Clin & Policlin, Dept Med, Basel, Switzerland; [Lorscheider, Johannes] Univ Basel, Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland; [Lorscheider, Johannes] Univ Basel, Univ Hosp Basel, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland; [Vukusic, Sandra] Hosp Civils Lyon, Serv Neurol A, Hop Neurol, Lyon Bron, France; [Trojano, Maria; Iaffaldano, Pietro] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Hillert, Jan; Spelman, Tim] Karolinska Inst, Clin Neurosci, Stockholm, Sweden; [Hyde, Robert; Pellegrini, Fabio] Biogen Int, Zurich, Switzerland; [Magyari, Melinda; Sorensen, Per Soelberg] Rigshosp, Danish Multiple Sclerosis Ctr, Dept Neurol, Copenhagen, Denmark; [Koch-Henriksen, Nils] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Spelman, Tim] Box Hill Hosp, Dept Neurol, Melbourne, Vic, Australia; [van Der Walt, Anneke] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Horakova, Dana; Havrdova, Eva] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Horakova, Dana; Havrdova, Eva] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Horakova, Dana; Havrdova, Eva] Gen Univ Hosp Prague, Prague, Czech Republic; [Girard, Marc] CHUM, Montreal, PQ, Canada; [Girard, Marc] Univ Montreal, Montreal, PQ, Canada; [Eichau, Sara] Hosp Univ Virgen Macarena, Neurol, Seville, Spain; [Grand'Maison, Francois] Neuro Rive Sud, Quebec City, PQ, Canada; [Gerlach, Oliver] Zuyderland Med Ctr, Dept Neurol, Sittard Geleen, Netherlands; [Gerlach, Oliver] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Terzi, Murat] Ondokuz Mayis Univ, Samsun, Turkey; [Ozakbas, Serkan] Dokuz Eylul Univ, Izmir, Turkey; [Skibina, Olga] Box Hill Hosp, Neurol, Melbourne, Vic, Australia; [Skibina, Olga] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic, Australia; [Van Pesch, Vincent] Clin Univ St Luc, Neurol, Brussels, Belgium; [Sa, Maria Jose] Ctr Hosp Sao Joao, Neurol, Porto, Portugal; [Sa, Maria Jose] Univ Fernando Pessoa, Fac Hlth Sci, Porto, Portugal; [Prevost, Julie] Ctr Integre Sante & Serv Sociaux Laurentides Poin, St Jerome, PQ, Canada; [Alroughani, Raed] Amiri Hosp, Kuwait, Kuwait; [McCombe, Pamela A.] Univ Queensland, UQCCR, Brisbane, Qld, Australia; [Gouider, Riadh] Razi Hosp, Dept Neurol, Manouba, Tunisia; [Mrabet, Saloua] Razi Univ Hosp, Dept Neurol, Manouba, Tunisia; [Mrabet, Saloua] Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia; [Castillo-Trivino, Tamara] Donostia Univ Hosp, Neurol, San Sebastian, Spain; [Zhu, Chao; Butzkueven, Helmut] Monash Univ, Ctr Clin Sch, Neurosci, Melbourne, Vic, Australia; [de Gans, Koen] Groene Hart Ziekenhuis, Gouda, Netherlands; [Luis Sanchez-Menoyo, Jose] Galdakao Hosp, Neurol, Vizcaya, Spain; [Yamout, Bassem; Khoury, Samia] Amer Univ Beirut, Nehme & Therese Tohme Multiple Sclerosis Ctr, Med Ctr, Beirut, Lebanon; [Kalincik, Tomas] Univ Melbourne, Dept Med, CORE, Melbourne, Vic, Australia; [Kalincik, Tomas] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; [Butzkueven, Helmut] MSBase Fdn, Melbourne, Vic, Australiaen_US
dc.descriptionTomas, Frédéric/0000-0003-0197-3368; Hillert, Jan/0000-0002-7386-6732; Lorscheider, Johannes/0000-0003-1100-2506; Sánchez Menoyo, José Luis/0000-0003-2634-8294; Signori, Alessio/0000-0001-6289-9144; Zhu, Chao/0000-0003-3951-7501; Iaffaldano, Pietro/0000-0003-2308-1731; Gouider, Riadh/0000-0001-9615-3797; Magyari, Melinda/0000-0002-0972-5222; Mrabet, Saloua/0000-0003-2718-1828;en_US
dc.description.abstractBackground Over the decades, several natural history studies on patients with primary (PPMS) or secondary progressive multiple sclerosis (SPMS) were reported from international registries. In PPMS, a consistent heterogeneity on long-term disability trajectories was demonstrated. The aim of this study was to identify subgroups of patients with SPMS with similar longitudinal trajectories of disability over time. Methods All patients with MS collected within Big MS registries who received an SPMS diagnosis from physicians (cohort 1) or satisfied the Lorscheider criteria (cohort 2) were considered. Longitudinal Expanded Disability Status Scale (EDSS) scores were modelled by a latent class growth analysis (LCGA), using a non-linear function of time from the first EDSS visit in the range 3-4. Results A total of 3613 patients with SPMS were included in the cohort 1. LCGA detected three different subgroups of patients with a mild (n=1297; 35.9%), a moderate (n=1936; 53.6%) and a severe (n=380; 10.5%) disability trajectory. Median time to EDSS 6 was 12.1, 5.0 and 1.7 years, for the three groups, respectively; the probability to reach EDSS 6 at 8 years was 14.4%, 78.4% and 98.3%, respectively. Similar results were found among 7613 patients satisfying the Lorscheider criteria. Conclusions Contrary to previous interpretations, patients with SPMS progress at greatly different rates. Our identification of distinct trajectories can guide better patient selection in future phase 3 SPMS clinical trials. Additionally, distinct trajectories could reflect heterogeneous pathological mechanisms of progression.en_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.doi10.1136/jnnp-2022-329987
dc.identifier.endpage30en_US
dc.identifier.issn0022-3050
dc.identifier.issn1468-330X
dc.identifier.issue1en_US
dc.identifier.pmid36171104
dc.identifier.scopus2-s2.0-85144239897
dc.identifier.scopusqualityQ1
dc.identifier.startpage23en_US
dc.identifier.urihttps://doi.org/10.1136/jnnp-2022-329987
dc.identifier.urihttps://hdl.handle.net/20.500.12712/45217
dc.identifier.volume94en_US
dc.identifier.wosWOS:000863392500001
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.ispartofJournal of Neurology Neurosurgery and Psychiatryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMultiple Sclerosisen_US
dc.subjectStatisticsen_US
dc.titleHeterogeneity on Long-Term Disability Trajectories in Patients With Secondary Progressive MS: A Latent Class Analysis From Big MS Data Networken_US
dc.typeArticleen_US
dspace.entity.typePublication

Files